Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting

被引:7
作者
Cole, Calvin L. [1 ,2 ,3 ,4 ,5 ]
Bachman, John F. [6 ,7 ]
Ye, Jian [3 ]
Murphy, Joseph [3 ]
Gerber, Scott A. [3 ,5 ,8 ,9 ]
Beck, Christopher A. [1 ,10 ]
Boyce, Brendan F. [2 ,5 ]
Muthukrishnan, Gowrishankar [1 ,2 ]
Chakkalakal, Joe V. [2 ,5 ,7 ]
Schwarz, Edward M. [1 ,2 ,5 ]
Linehan, David [3 ,5 ]
机构
[1] Univ Rochester, Med Ctr, Dept Orthopaed, 601 Elmwood Ave,Box 665, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA
[3] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA
[4] Univ Rochester, Med Ctr, Div Support Care Canc, Rochester, NY 14642 USA
[5] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA
[6] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
[7] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, Rochester, NY 14642 USA
[8] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[9] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA
[10] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA
基金
美国国家卫生研究院;
关键词
Myocellular lipid; Murine model; Pancreatic cancer; Skeletal muscle wasting; GROWTH; SARCOPENIA; CYTOKINES; INFLAMMATION; CONTRIBUTES; SURVIVAL; MICE;
D O I
10.1002/jcsm.12699
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Skeletal muscle wasting (SMW) in cancer patients is associated with increased morbidity, mortality, treatment intolerance and discontinuation, and poor quality of life. This is particularly true for patients with pancreatic ductal adenocarcinoma (PDAC), as over 85% experience SMW, which is responsible for similar to 30% of patient deaths. While the established paradigm to explain SMW posits that muscle catabolism from systemic inflammation and nutritional deficiencies, the cause of death, and the cellular and molecular mechanisms responsible remain to be elucidated. To address this, we investigated the relationship between tumour burden and survival in the KCKO murine PDAC model. Methods Female C57BL/6J mice 6-8 weeks of age underwent orthotopic injection with KCKO-luc tumour cells. Solid tumour was verified on Day 5, post-tumour inoculation. In vivo, longitudinal lean mass and tumour burden were assessed via dual-energy X-ray absorptiometry and IVIS imaging, respectively, and total body weight was assessed, weekly. Animals were sacrificed at a designated end point of 'failure to thrive'. After sacrifice, lower limb hind muscles were harvested for histology and RNA extraction. Results We found a strong correlation between primary tumour size and survival (r(2) = 0.83, P < 0.0001). A significant decrease in lower limb lean mass was first detected at Day 38 post-implantation vs. no tumour controls (NTCs) (P < 0.0001). SMW was confirmed by histology, which demonstrated a 38%, 32.7%, and 39.9% decrease in fibre size of extensor digitorum longus, soleus, and tibialis anterior muscles, respectively, in PDAC mice vs. NTC (P < 0.002). Histology also revealed a 67.6% increase in haematopoietic cells within the muscle of PDAC mice when compared with NTC. Bulk RNAseq on muscles from PDAC mice vs. NTC revealed significant increases in c/ebp beta/Delta, il-1, il-6, and tnf gene expression. Pathway analyses to identify potential upstream factors revealed increased adipogenic gene expression, including a four-fold increase in igfbp-3. Histomorphometry of Oil Red-O staining for fat content in tibialis anterior muscles demonstrated a 95.5% increase in positively stained fibres from PDAC mice vs. NTC. Conclusions Together, these findings support a novel model of PDAC-associated SMW and mortality in which systemic inflammation leads to inflammatory cell infiltration into skeletal muscle with up-regulated myocellular lipids.
引用
收藏
页码:731 / 745
页数:15
相关论文
共 45 条
  • [41] Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma
    Xue, Aiqun
    Scarlett, Christopher J.
    Jackson, Christopher J.
    Allen, Barry J.
    Smith, Ross C.
    [J]. PANCREAS, 2008, 36 (02) : 160 - 167
  • [42] Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
    Yakovenko, Anastasiya
    Cameron, Miles
    Trevino, Jose Gilberto
    [J]. WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 10 (09): : 95 - 106
  • [43] Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
    Yoneyama, Toshihiro
    Ohtsuki, Sumio
    Honda, Kazufumi
    Kobayashi, Makoto
    Iwasaki, Motoki
    Uchida, Yasuo
    Okusaka, Takuji
    Nakamori, Shoji
    Shimahara, Masashi
    Ueno, Takaaki
    Tsuchida, Akihiko
    Sata, Naohiro
    Ioka, Tatsuya
    Yasunami, Yohichi
    Kosuge, Tomoo
    Kaneda, Takashi
    Kato, Takao
    Yagihara, Kazuhiro
    Fujita, Shigeyuki
    Huang, Wilber
    Yamada, Tesshi
    Tachikawa, Masanori
    Terasaki, Tetsuya
    [J]. PLOS ONE, 2016, 11 (08):
  • [44] Challenges in diagnosis of pancreatic cancer
    Zhang, Lulu
    Sanagapalli, Santosh
    Stoita, Alina
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (19) : 2047 - 2060
  • [45] Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review
    Zhang, Xiao-Ming
    Dou, Qing-Li
    Zeng, Yingchun
    Yang, Yunzhi
    Cheng, Andy S. K.
    Zhang, Wen-Wu
    [J]. BMC CANCER, 2020, 20 (01)